{"url":"https://lda.senate.gov/api/v1/filings/aece29b2-047f-4e16-81c5-334dfdff07cc/","filing_uuid":"aece29b2-047f-4e16-81c5-334dfdff07cc","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2010,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/aece29b2-047f-4e16-81c5-334dfdff07cc/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Martin Green, Consultant","dt_posted":"2010-07-16T17:02:12.797000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1101 Pennsylvania Avenue, N.W.","registrant_address_2":"Suite 700","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":400427061,"url":"https://lda.senate.gov/api/v1/registrants/400427061/","house_registrant_id":40690,"name":"MARTIN GREEN","description":"Marketing and Government Relations","address_1":"1101 Pennsylvania Avenue, N.W.","address_2":"Suite 700","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MARTIN GREEN","contact_telephone":"+1 202-756-4512","dt_updated":"2022-04-06T16:07:13.702070-04:00"},"client":{"id":190686,"url":"https://lda.senate.gov/api/v1/clients/190686/","client_id":113,"name":"FABIANI & COMPANY ON BEHALF OF VARIATION BIOTECHNOLOGIES","general_description":"Vaccine company","client_government_entity":false,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2010-01-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Funding for vaccine research and development","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":47587,"prefix":null,"prefix_display":null,"first_name":"MARTIN","nickname":null,"middle_name":null,"last_name":"GREEN","suffix":null,"suffix_display":null},"covered_position":"Deputy Chief of Staff, Rep. Mark Souder","new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}